nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.00249	0.0225	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGFBP5—breast cancer	0.00235	0.0213	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ADAMTS1—breast cancer	0.00228	0.0206	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—MUC2—breast cancer	0.00221	0.02	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EEF1B2—breast cancer	0.00215	0.0194	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.00182	0.0164	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.00165	0.0149	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.00165	0.0149	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ATF4—breast cancer	0.00163	0.0147	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.00156	0.0141	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—THBS1—breast cancer	0.00149	0.0135	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2S2—breast cancer	0.00147	0.0133	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.00143	0.0129	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—INHBB—breast cancer	0.00135	0.0122	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CCT5—breast cancer	0.00135	0.0122	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.00133	0.012	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EEF2—breast cancer	0.00129	0.0117	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.00129	0.0116	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPL31—breast cancer	0.00121	0.011	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PLAUR—breast cancer	0.00121	0.0109	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.00118	0.0107	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.00117	0.0106	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.00114	0.0103	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPS4X—breast cancer	0.00113	0.0102	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF3A—breast cancer	0.00111	0.0101	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—DDIT3—breast cancer	0.00111	0.0101	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SYNJ2—breast cancer	0.00111	0.01	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ADAMTS1—breast cancer	0.00108	0.00976	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MUC2—breast cancer	0.00105	0.0095	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NDUFS3—breast cancer	0.00103	0.00932	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PABPC1—breast cancer	0.000999	0.00903	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000991	0.00896	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MME—breast cancer	0.000987	0.00893	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—TUBB3—breast cancer	0.000976	0.00883	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CHST9—breast cancer	0.000969	0.00876	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.000947	0.00856	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.000921	0.00833	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—COX11—breast cancer	0.000918	0.00831	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPL23A—breast cancer	0.000918	0.0083	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000903	0.00817	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.000876	0.00792	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPS8—breast cancer	0.000856	0.00774	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPS7—breast cancer	0.000856	0.00774	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SHMT1—breast cancer	0.00084	0.0076	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CDA—breast cancer	0.00084	0.0076	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000829	0.0075	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.000821	0.00743	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLCO1B1—breast cancer	0.000809	0.00731	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC2A5—breast cancer	0.000809	0.00731	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.00079	0.00715	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APRT—breast cancer	0.000781	0.00706	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGFBP3—breast cancer	0.000776	0.00701	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000766	0.00693	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000763	0.0069	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ACHE—breast cancer	0.000757	0.00685	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ESRRA—breast cancer	0.000734	0.00664	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ANGPTL4—breast cancer	0.000734	0.00664	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CTSD—breast cancer	0.000717	0.00648	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—THBS1—breast cancer	0.000706	0.00638	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000698	0.00631	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPI—breast cancer	0.000696	0.0063	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HADHB—breast cancer	0.000696	0.0063	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000666	0.00602	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALDH7A1—breast cancer	0.000664	0.00601	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALDH1A1—breast cancer	0.000664	0.00601	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—BCHE—breast cancer	0.00066	0.00596	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000656	0.00594	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPS6—breast cancer	0.000644	0.00582	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FHL2—breast cancer	0.000637	0.00576	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NME1—breast cancer	0.000637	0.00576	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PHGDH—breast cancer	0.000637	0.00576	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UMPS—breast cancer	0.000637	0.00576	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADSL—breast cancer	0.000637	0.00576	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LDHB—breast cancer	0.000624	0.00565	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HPSE—breast cancer	0.000624	0.00565	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—BRIP1—breast cancer	0.000624	0.00565	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—TCF7L2—breast cancer	0.000614	0.00555	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCC1—breast cancer	0.000592	0.00535	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA3—breast cancer	0.000592	0.00535	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HMMR—breast cancer	0.000592	0.00535	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLAUR—breast cancer	0.000574	0.00519	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARGC1B—breast cancer	0.000573	0.00518	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLG—breast cancer	0.000561	0.00507	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000558	0.00505	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000558	0.00505	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA4—breast cancer	0.000541	0.0049	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CA9—breast cancer	0.000541	0.0049	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000534	0.00483	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000529	0.00478	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA2—breast cancer	0.000528	0.00477	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPX2—breast cancer	0.000528	0.00477	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPX4—breast cancer	0.000521	0.00471	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SULT1A1—breast cancer	0.000521	0.00471	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—IDH1—breast cancer	0.000509	0.0046	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTA1—breast cancer	0.000509	0.0046	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NAT2—breast cancer	0.000503	0.00455	CbGpPWpGaD
Zanamivir—Syncope—Docetaxel—breast cancer	0.00049	0.000551	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—breast cancer	0.00049	0.000551	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—breast cancer	0.00049	0.000551	CcSEcCtD
Zanamivir—Body temperature increased—Fluorouracil—breast cancer	0.000489	0.000549	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—breast cancer	0.00048	0.00054	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.00048	0.000539	CcSEcCtD
Zanamivir—Malaise—Capecitabine—breast cancer	0.000477	0.000537	CcSEcCtD
Zanamivir—Cough—Docetaxel—breast cancer	0.000477	0.000536	CcSEcCtD
Zanamivir—Hypersensitivity—Mitoxantrone—breast cancer	0.000476	0.000535	CcSEcCtD
Zanamivir—Hypersensitivity—Irinotecan—breast cancer	0.000476	0.000535	CcSEcCtD
Zanamivir—Vomiting—Thiotepa—breast cancer	0.000475	0.000534	CcSEcCtD
Zanamivir—Syncope—Capecitabine—breast cancer	0.000475	0.000534	CcSEcCtD
Zanamivir—Convulsion—Docetaxel—breast cancer	0.000474	0.000533	CcSEcCtD
Zanamivir—Rash—Thiotepa—breast cancer	0.000471	0.00053	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—breast cancer	0.000471	0.000529	CcSEcCtD
Zanamivir—Dermatitis—Thiotepa—breast cancer	0.000471	0.000529	CcSEcCtD
Zanamivir—Dyspnoea—Paclitaxel—breast cancer	0.000469	0.000528	CcSEcCtD
Zanamivir—Headache—Thiotepa—breast cancer	0.000468	0.000526	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000468	0.000526	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—breast cancer	0.000465	0.000523	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—breast cancer	0.000465	0.000523	CcSEcCtD
Zanamivir—Loss of consciousness—Capecitabine—breast cancer	0.000465	0.000523	CcSEcCtD
Zanamivir—Nausea—Vinorelbine—breast cancer	0.000465	0.000523	CcSEcCtD
Zanamivir—Asthenia—Mitoxantrone—breast cancer	0.000463	0.000521	CcSEcCtD
Zanamivir—Asthenia—Irinotecan—breast cancer	0.000463	0.000521	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000462	0.00052	CcSEcCtD
Zanamivir—Cough—Capecitabine—breast cancer	0.000462	0.000519	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—breast cancer	0.000458	0.000515	CcSEcCtD
Zanamivir—Decreased appetite—Paclitaxel—breast cancer	0.000458	0.000514	CcSEcCtD
Zanamivir—Hypersensitivity—Fluorouracil—breast cancer	0.000455	0.000512	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000455	0.00411	CbGpPWpGaD
Zanamivir—Haemoglobin—Methotrexate—breast cancer	0.000455	0.000511	CcSEcCtD
Zanamivir—Fatigue—Paclitaxel—breast cancer	0.000454	0.00051	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—breast cancer	0.000453	0.000509	CcSEcCtD
Zanamivir—Asthenia—Gemcitabine—breast cancer	0.000451	0.000507	CcSEcCtD
Zanamivir—Arthralgia—Capecitabine—breast cancer	0.000451	0.000507	CcSEcCtD
Zanamivir—Myalgia—Capecitabine—breast cancer	0.000451	0.000507	CcSEcCtD
Zanamivir—Pain—Paclitaxel—breast cancer	0.00045	0.000506	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—breast cancer	0.00045	0.000506	CcSEcCtD
Zanamivir—Anxiety—Capecitabine—breast cancer	0.000449	0.000505	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000447	0.000503	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—breast cancer	0.000446	0.000502	CcSEcCtD
Zanamivir—Discomfort—Capecitabine—breast cancer	0.000445	0.000501	CcSEcCtD
Zanamivir—Nausea—Thiotepa—breast cancer	0.000444	0.000499	CcSEcCtD
Zanamivir—Infection—Docetaxel—breast cancer	0.000443	0.000498	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—breast cancer	0.000443	0.000498	CcSEcCtD
Zanamivir—Diarrhoea—Mitoxantrone—breast cancer	0.000442	0.000496	CcSEcCtD
Zanamivir—Diarrhoea—Irinotecan—breast cancer	0.000442	0.000496	CcSEcCtD
Zanamivir—NEU2—Metabolism—MED12—breast cancer	0.000441	0.00399	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—DPYD—breast cancer	0.000441	0.00399	CbGpPWpGaD
Zanamivir—Shock—Docetaxel—breast cancer	0.000439	0.000494	CcSEcCtD
Zanamivir—Confusional state—Capecitabine—breast cancer	0.000436	0.00049	CcSEcCtD
Zanamivir—NEU2—Metabolism—ALDOA—breast cancer	0.000434	0.00393	CbGpPWpGaD
Zanamivir—Feeling abnormal—Paclitaxel—breast cancer	0.000434	0.000488	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—breast cancer	0.000433	0.000487	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000433	0.000487	CcSEcCtD
Zanamivir—Gastrointestinal pain—Paclitaxel—breast cancer	0.00043	0.000484	CcSEcCtD
Zanamivir—Diarrhoea—Gemcitabine—breast cancer	0.00043	0.000484	CcSEcCtD
Zanamivir—Infection—Capecitabine—breast cancer	0.000429	0.000482	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—breast cancer	0.000428	0.000481	CcSEcCtD
Zanamivir—Dizziness—Irinotecan—breast cancer	0.000427	0.00048	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—breast cancer	0.000426	0.000479	CcSEcCtD
Zanamivir—Anorexia—Docetaxel—breast cancer	0.000425	0.000478	CcSEcCtD
Zanamivir—Shock—Capecitabine—breast cancer	0.000425	0.000478	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—breast cancer	0.000424	0.000476	CcSEcCtD
Zanamivir—Diarrhoea—Fluorouracil—breast cancer	0.000423	0.000476	CcSEcCtD
Zanamivir—NEU2—Metabolism—NCOA3—breast cancer	0.000422	0.00381	CbGpPWpGaD
Zanamivir—Skin disorder—Capecitabine—breast cancer	0.00042	0.000472	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC2A2—breast cancer	0.000419	0.00379	CbGpPWpGaD
Zanamivir—Urticaria—Paclitaxel—breast cancer	0.000418	0.00047	CcSEcCtD
Zanamivir—Abdominal pain—Paclitaxel—breast cancer	0.000416	0.000468	CcSEcCtD
Zanamivir—Body temperature increased—Paclitaxel—breast cancer	0.000416	0.000468	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000414	0.00375	CbGpPWpGaD
Zanamivir—Anorexia—Capecitabine—breast cancer	0.000412	0.000463	CcSEcCtD
Zanamivir—Vomiting—Irinotecan—breast cancer	0.00041	0.000461	CcSEcCtD
Zanamivir—Vomiting—Mitoxantrone—breast cancer	0.00041	0.000461	CcSEcCtD
Zanamivir—NEU2—Metabolism—MTR—breast cancer	0.00041	0.00371	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CPT1A—breast cancer	0.00041	0.00371	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCG2—breast cancer	0.00041	0.00371	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP1—breast cancer	0.00041	0.00371	CbGpPWpGaD
Zanamivir—Sinusitis—Doxorubicin—breast cancer	0.00041	0.000461	CcSEcCtD
Zanamivir—Dizziness—Fluorouracil—breast cancer	0.000409	0.00046	CcSEcCtD
Zanamivir—Rash—Mitoxantrone—breast cancer	0.000407	0.000458	CcSEcCtD
Zanamivir—Rash—Irinotecan—breast cancer	0.000407	0.000458	CcSEcCtD
Zanamivir—Dermatitis—Mitoxantrone—breast cancer	0.000407	0.000457	CcSEcCtD
Zanamivir—Dermatitis—Irinotecan—breast cancer	0.000407	0.000457	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000406	0.000457	CcSEcCtD
Zanamivir—Chills—Methotrexate—breast cancer	0.000406	0.000457	CcSEcCtD
Zanamivir—Headache—Irinotecan—breast cancer	0.000404	0.000455	CcSEcCtD
Zanamivir—Headache—Mitoxantrone—breast cancer	0.000404	0.000455	CcSEcCtD
Zanamivir—NEU2—Metabolism—HPGDS—breast cancer	0.000402	0.00364	CbGpPWpGaD
Zanamivir—Erythema multiforme—Epirubicin—breast cancer	0.0004	0.00045	CcSEcCtD
Zanamivir—NEU2—Metabolism—HBA1—breast cancer	0.0004	0.00362	CbGpPWpGaD
Zanamivir—Vomiting—Gemcitabine—breast cancer	0.0004	0.000449	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—breast cancer	0.000398	0.000447	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—LEP—breast cancer	0.000397	0.00359	CbGpPWpGaD
Zanamivir—Rash—Gemcitabine—breast cancer	0.000396	0.000446	CcSEcCtD
Zanamivir—Dermatitis—Gemcitabine—breast cancer	0.000396	0.000445	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—breast cancer	0.000394	0.000443	CcSEcCtD
Zanamivir—Headache—Gemcitabine—breast cancer	0.000394	0.000443	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000394	0.000442	CcSEcCtD
Zanamivir—Vomiting—Fluorouracil—breast cancer	0.000393	0.000442	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—breast cancer	0.000392	0.000441	CcSEcCtD
Zanamivir—NEU2—Metabolism—ACHE—breast cancer	0.00039	0.00353	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTT1—breast cancer	0.00039	0.00353	CbGpPWpGaD
Zanamivir—Rash—Fluorouracil—breast cancer	0.00039	0.000438	CcSEcCtD
Zanamivir—Dermatitis—Fluorouracil—breast cancer	0.000389	0.000438	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—breast cancer	0.000388	0.000436	CcSEcCtD
Zanamivir—Hypersensitivity—Paclitaxel—breast cancer	0.000388	0.000436	CcSEcCtD
Zanamivir—Headache—Fluorouracil—breast cancer	0.000387	0.000435	CcSEcCtD
Zanamivir—Dyspnoea—Capecitabine—breast cancer	0.000385	0.000433	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—breast cancer	0.000385	0.000432	CcSEcCtD
Zanamivir—Nausea—Mitoxantrone—breast cancer	0.000383	0.000431	CcSEcCtD
Zanamivir—Nausea—Irinotecan—breast cancer	0.000383	0.000431	CcSEcCtD
Zanamivir—Pain—Docetaxel—breast cancer	0.000382	0.000429	CcSEcCtD
Zanamivir—Chills—Epirubicin—breast cancer	0.00038	0.000427	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—breast cancer	0.000378	0.000425	CcSEcCtD
Zanamivir—Asthenia—Paclitaxel—breast cancer	0.000378	0.000425	CcSEcCtD
Zanamivir—Decreased appetite—Capecitabine—breast cancer	0.000376	0.000422	CcSEcCtD
Zanamivir—Nausea—Gemcitabine—breast cancer	0.000373	0.00042	CcSEcCtD
Zanamivir—Fatigue—Capecitabine—breast cancer	0.000372	0.000419	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—breast cancer	0.000371	0.000417	CcSEcCtD
Zanamivir—Pain—Capecitabine—breast cancer	0.000369	0.000415	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP17A1—breast cancer	0.000369	0.00334	CbGpPWpGaD
Zanamivir—Feeling abnormal—Docetaxel—breast cancer	0.000368	0.000413	CcSEcCtD
Zanamivir—Nausea—Fluorouracil—breast cancer	0.000367	0.000413	CcSEcCtD
Zanamivir—NEU2—Metabolism—ENO1—breast cancer	0.000366	0.00331	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS1—breast cancer	0.000366	0.00331	CbGpPWpGaD
Zanamivir—Ill-defined disorder—Methotrexate—breast cancer	0.000366	0.000411	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—breast cancer	0.000365	0.00041	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000364	0.00329	CbGpPWpGaD
Zanamivir—Diarrhoea—Paclitaxel—breast cancer	0.00036	0.000405	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.00036	0.00325	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP2D6—breast cancer	0.000359	0.00324	CbGpPWpGaD
Zanamivir—Feeling abnormal—Capecitabine—breast cancer	0.000356	0.0004	CcSEcCtD
Zanamivir—Malaise—Methotrexate—breast cancer	0.000355	0.000399	CcSEcCtD
Zanamivir—Gastrointestinal pain—Capecitabine—breast cancer	0.000353	0.000397	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—breast cancer	0.000353	0.000397	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—breast cancer	0.000353	0.000397	CcSEcCtD
Zanamivir—NEU2—Metabolism—NCOA2—breast cancer	0.000352	0.00318	CbGpPWpGaD
Zanamivir—Chills—Doxorubicin—breast cancer	0.000352	0.000395	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—breast cancer	0.00035	0.000394	CcSEcCtD
Zanamivir—Dizziness—Paclitaxel—breast cancer	0.000348	0.000391	CcSEcCtD
Zanamivir—Cough—Methotrexate—breast cancer	0.000344	0.000387	CcSEcCtD
Zanamivir—Urticaria—Capecitabine—breast cancer	0.000343	0.000386	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—breast cancer	0.000342	0.000385	CcSEcCtD
Zanamivir—Body temperature increased—Capecitabine—breast cancer	0.000341	0.000384	CcSEcCtD
Zanamivir—Abdominal pain—Capecitabine—breast cancer	0.000341	0.000384	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—breast cancer	0.000341	0.000384	CcSEcCtD
Zanamivir—NEU2—Metabolism—FASN—breast cancer	0.000341	0.00309	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—BCHE—breast cancer	0.00034	0.00307	CbGpPWpGaD
Zanamivir—Agitation—Epirubicin—breast cancer	0.000339	0.000381	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC5A5—breast cancer	0.000336	0.00304	CbGpPWpGaD
Zanamivir—Arthralgia—Methotrexate—breast cancer	0.000335	0.000377	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—breast cancer	0.000335	0.000377	CcSEcCtD
Zanamivir—Vomiting—Paclitaxel—breast cancer	0.000335	0.000376	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000333	0.000375	CcSEcCtD
Zanamivir—Malaise—Epirubicin—breast cancer	0.000333	0.000374	CcSEcCtD
Zanamivir—Rash—Paclitaxel—breast cancer	0.000332	0.000373	CcSEcCtD
Zanamivir—Dermatitis—Paclitaxel—breast cancer	0.000332	0.000373	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—breast cancer	0.000331	0.000373	CcSEcCtD
Zanamivir—Syncope—Epirubicin—breast cancer	0.000331	0.000372	CcSEcCtD
Zanamivir—Headache—Paclitaxel—breast cancer	0.00033	0.000371	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—breast cancer	0.000329	0.00037	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—IGF1—breast cancer	0.000328	0.00297	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NQO1—breast cancer	0.000324	0.00293	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC2A1—breast cancer	0.000324	0.00293	CbGpPWpGaD
Zanamivir—Confusional state—Methotrexate—breast cancer	0.000324	0.000365	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—breast cancer	0.000324	0.000364	CcSEcCtD
Zanamivir—Cough—Epirubicin—breast cancer	0.000322	0.000362	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—breast cancer	0.000322	0.000362	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—breast cancer	0.00032	0.00036	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—breast cancer	0.000319	0.000359	CcSEcCtD
Zanamivir—Infection—Methotrexate—breast cancer	0.000319	0.000359	CcSEcCtD
Zanamivir—Hypersensitivity—Capecitabine—breast cancer	0.000318	0.000358	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000318	0.00287	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP2—breast cancer	0.000317	0.00287	CbGpPWpGaD
Zanamivir—Ill-defined disorder—Doxorubicin—breast cancer	0.000317	0.000356	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP3A4—breast cancer	0.000316	0.00286	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000315	0.00285	CbGpPWpGaD
Zanamivir—Myalgia—Epirubicin—breast cancer	0.000314	0.000353	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—breast cancer	0.000314	0.000353	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—breast cancer	0.000314	0.000353	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—breast cancer	0.000313	0.000352	CcSEcCtD
Zanamivir—Nausea—Paclitaxel—breast cancer	0.000313	0.000352	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—breast cancer	0.000312	0.000351	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000312	0.000351	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP1B1—breast cancer	0.000311	0.00281	CbGpPWpGaD
Zanamivir—Discomfort—Epirubicin—breast cancer	0.00031	0.000349	CcSEcCtD
Zanamivir—Asthenia—Capecitabine—breast cancer	0.00031	0.000348	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—breast cancer	0.000308	0.000346	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—breast cancer	0.000307	0.000345	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—breast cancer	0.000306	0.000344	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—breast cancer	0.000305	0.000343	CcSEcCtD
Zanamivir—NEU2—Metabolism—HSP90AA1—breast cancer	0.000305	0.00276	CbGpPWpGaD
Zanamivir—Confusional state—Epirubicin—breast cancer	0.000303	0.000341	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—breast cancer	0.000301	0.000338	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—breast cancer	0.0003	0.000337	CcSEcCtD
Zanamivir—Infection—Epirubicin—breast cancer	0.000299	0.000336	CcSEcCtD
Zanamivir—Cough—Doxorubicin—breast cancer	0.000298	0.000335	CcSEcCtD
Zanamivir—NEU2—Metabolism—NCOA1—breast cancer	0.000297	0.00268	CbGpPWpGaD
Zanamivir—Shock—Epirubicin—breast cancer	0.000296	0.000333	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—breast cancer	0.000296	0.000332	CcSEcCtD
Zanamivir—Diarrhoea—Capecitabine—breast cancer	0.000296	0.000332	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—breast cancer	0.000295	0.000332	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000293	0.000329	CcSEcCtD
Zanamivir—NEU2—Metabolism—STK11—breast cancer	0.000292	0.00264	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP19A1—breast cancer	0.000292	0.00264	CbGpPWpGaD
Zanamivir—Skin disorder—Epirubicin—breast cancer	0.000292	0.000329	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—breast cancer	0.00029	0.000327	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—breast cancer	0.00029	0.000327	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—breast cancer	0.000289	0.000325	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000288	0.000324	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—breast cancer	0.000287	0.000323	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—breast cancer	0.000287	0.000323	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—breast cancer	0.000287	0.000322	CcSEcCtD
Zanamivir—Dizziness—Capecitabine—breast cancer	0.000286	0.000321	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—breast cancer	0.000284	0.000319	CcSEcCtD
Zanamivir—Rash—Docetaxel—breast cancer	0.000281	0.000316	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—breast cancer	0.000281	0.000316	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—breast cancer	0.000281	0.000316	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—breast cancer	0.00028	0.000314	CcSEcCtD
Zanamivir—Headache—Docetaxel—breast cancer	0.00028	0.000314	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—breast cancer	0.000278	0.000313	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—breast cancer	0.000277	0.000312	CcSEcCtD
Zanamivir—Infection—Doxorubicin—breast cancer	0.000277	0.000311	CcSEcCtD
Zanamivir—Pain—Methotrexate—breast cancer	0.000275	0.000309	CcSEcCtD
Zanamivir—Vomiting—Capecitabine—breast cancer	0.000275	0.000309	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000274	0.00248	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000274	0.000308	CcSEcCtD
Zanamivir—Shock—Doxorubicin—breast cancer	0.000274	0.000308	CcSEcCtD
Zanamivir—Rash—Capecitabine—breast cancer	0.000272	0.000306	CcSEcCtD
Zanamivir—Dermatitis—Capecitabine—breast cancer	0.000272	0.000306	CcSEcCtD
Zanamivir—NEU2—Metabolism—COMT—breast cancer	0.000272	0.00246	CbGpPWpGaD
Zanamivir—Headache—Capecitabine—breast cancer	0.000271	0.000304	CcSEcCtD
Zanamivir—NEU2—Metabolism—GSTP1—breast cancer	0.00027	0.00245	CbGpPWpGaD
Zanamivir—Skin disorder—Doxorubicin—breast cancer	0.00027	0.000304	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—breast cancer	0.000268	0.000302	CcSEcCtD
Zanamivir—NEU2—Metabolism—HMOX1—breast cancer	0.000267	0.00241	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ITPR1—breast cancer	0.000266	0.00241	CbGpPWpGaD
Zanamivir—Anorexia—Doxorubicin—breast cancer	0.000265	0.000298	CcSEcCtD
Zanamivir—Nausea—Docetaxel—breast cancer	0.000265	0.000298	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—breast cancer	0.000265	0.000298	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—CXCL8—breast cancer	0.000264	0.00238	CbGpPWpGaD
Zanamivir—Gastrointestinal pain—Methotrexate—breast cancer	0.000263	0.000296	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—breast cancer	0.000262	0.000294	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—breast cancer	0.000259	0.000292	CcSEcCtD
Zanamivir—Pain—Epirubicin—breast cancer	0.000257	0.000289	CcSEcCtD
Zanamivir—Nausea—Capecitabine—breast cancer	0.000257	0.000288	CcSEcCtD
Zanamivir—NEU2—Metabolism—ABCB1—breast cancer	0.000256	0.00232	CbGpPWpGaD
Zanamivir—Urticaria—Methotrexate—breast cancer	0.000255	0.000287	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—breast cancer	0.000254	0.000286	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—breast cancer	0.000254	0.000286	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000254	0.000285	CcSEcCtD
Zanamivir—NEU2—Metabolism—TYMS—breast cancer	0.000251	0.00227	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLA2G4A—breast cancer	0.000249	0.00225	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTM1—breast cancer	0.000249	0.00225	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NCOR1—breast cancer	0.000249	0.00225	CbGpPWpGaD
Zanamivir—Dyspnoea—Doxorubicin—breast cancer	0.000248	0.000279	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—breast cancer	0.000248	0.000279	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—breast cancer	0.000246	0.000277	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—CTNNB1—breast cancer	0.000243	0.0022	CbGpPWpGaD
Zanamivir—Decreased appetite—Doxorubicin—breast cancer	0.000242	0.000272	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—breast cancer	0.00024	0.00027	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—breast cancer	0.000239	0.000269	CcSEcCtD
Zanamivir—Pain—Doxorubicin—breast cancer	0.000238	0.000268	CcSEcCtD
Zanamivir—NEU2—Metabolism—GPX1—breast cancer	0.000238	0.00215	CbGpPWpGaD
Zanamivir—Abdominal pain—Epirubicin—breast cancer	0.000238	0.000267	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—breast cancer	0.000238	0.000267	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—breast cancer	0.000237	0.000266	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP1A1—breast cancer	0.000236	0.00213	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ERCC2—breast cancer	0.000234	0.00211	CbGpPWpGaD
Zanamivir—Asthenia—Methotrexate—breast cancer	0.000231	0.000259	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—breast cancer	0.000229	0.000258	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—breast cancer	0.000228	0.000256	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—breast cancer	0.000222	0.000249	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—breast cancer	0.000221	0.000249	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—breast cancer	0.00022	0.000247	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—breast cancer	0.00022	0.000247	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—breast cancer	0.00022	0.000247	CcSEcCtD
Zanamivir—NEU2—Metabolism—MTHFR—breast cancer	0.00022	0.00199	CbGpPWpGaD
Zanamivir—Asthenia—Epirubicin—breast cancer	0.000216	0.000243	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—breast cancer	0.000213	0.000239	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—breast cancer	0.000206	0.000231	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—breast cancer	0.000205	0.000231	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—breast cancer	0.000204	0.00023	CcSEcCtD
Zanamivir—Rash—Methotrexate—breast cancer	0.000203	0.000228	CcSEcCtD
Zanamivir—NEU2—Metabolism—CAV1—breast cancer	0.000203	0.00183	CbGpPWpGaD
Zanamivir—Dermatitis—Methotrexate—breast cancer	0.000203	0.000228	CcSEcCtD
Zanamivir—Headache—Methotrexate—breast cancer	0.000201	0.000226	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—breast cancer	0.0002	0.000225	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—breast cancer	0.000199	0.000224	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000194	0.00175	CbGpPWpGaD
Zanamivir—Vomiting—Epirubicin—breast cancer	0.000191	0.000215	CcSEcCtD
Zanamivir—Nausea—Methotrexate—breast cancer	0.000191	0.000215	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—breast cancer	0.000191	0.000214	CcSEcCtD
Zanamivir—Rash—Epirubicin—breast cancer	0.00019	0.000213	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—breast cancer	0.00019	0.000213	CcSEcCtD
Zanamivir—Headache—Epirubicin—breast cancer	0.000189	0.000212	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CG—breast cancer	0.000185	0.00167	CbGpPWpGaD
Zanamivir—Dizziness—Doxorubicin—breast cancer	0.000184	0.000207	CcSEcCtD
Zanamivir—Nausea—Epirubicin—breast cancer	0.000179	0.000201	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—breast cancer	0.000177	0.000199	CcSEcCtD
Zanamivir—Rash—Doxorubicin—breast cancer	0.000176	0.000197	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—breast cancer	0.000175	0.000197	CcSEcCtD
Zanamivir—Headache—Doxorubicin—breast cancer	0.000174	0.000196	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—breast cancer	0.000165	0.000186	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CD—breast cancer	0.000162	0.00147	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALB—breast cancer	0.00016	0.00145	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NOS3—breast cancer	0.000153	0.00139	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PIK3CB—breast cancer	0.000141	0.00128	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—breast cancer	0.00014	0.00127	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTEN—breast cancer	0.000122	0.00111	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PIK3CA—breast cancer	8.62e-05	0.00078	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKT1—breast cancer	7.04e-05	0.000637	CbGpPWpGaD
